Advertisement

Urine Is a Better Biomarker Source Than Blood Especially for Kidney Diseases

  • Youhe GaoEmail author
Chapter
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 845)

Abstract

Change is the soul of biomarker definition. Changes are more likely to be removed from blood because of homeostasis mechanisms of the body. Therefore, urine is probably a better biomarker source than blood. The road map to the urinary biomarker era is proposed. Researchers are reminded the potential opportunities and risks in their study design. Kidney diseases are emphasized as they produce most significant changes in urine.

Keywords

Change Homeostasis Confounding factors Animal model 

References

  1. 1.
    Biomarkers Definitions Working Group (2001) Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69:89–95CrossRefGoogle Scholar
  2. 2.
    IPCS (2001) Biomarkers in risk assessment: validity and validation environmental health criteria series 22 Google Scholar
  3. 3.
    Wikepedia (2014, October 11) Homeostasis. Wikipedia, the free encyclopedia http://en.wikipedia.org/w/index.php?title=Homeostasis&oldid=629140917
  4. 4.
    Gao Y (2013) Urine-an untapped goldmine for biomarker discovery? Sci China Life Sci 56:1145–1146Google Scholar
  5. 5.
    Wikipedia (2014, October 11) Biomarker (medicine). Wikipedia, the free encyclopedia http://en.wikipedia.org/w/index.php?title=Biomarker_(medicine)&oldid=622306690
  6. 6.
    Bouatra S, Aziat F, Mandal R, Guo AC, Wilson MR et al (2013) The human urine metabolome. PLoS One 8:e73076Google Scholar
  7. 7.
    Marimuthu A, O’Meally RN, Chaerkady R, Subbannayya Y, Nanjappa V et al (2011) A comprehensive map of the human urinary proteome. J Proteome Res 10:2734–2743Google Scholar
  8. 8.
    Kentsis A, Monigatti F, Dorff K, Campagne F, Bachur R et al (2009) Urine proteomics for profiling of human disease using high accuracy mass spectrometry. Proteomics Clin Appl 3:1052–1061Google Scholar
  9. 9.
    Menglin L, Mindi Z, Youhe G (2013) Changes of proteins induced by anticoagulants can be more sensitively detected in urine than in plasmaGoogle Scholar
  10. 10.
    Payne SR, Serth J, Schostak M, Kamradt J, Strauss A et al (2009) DNA methylation biomarkers of prostate cancer: confirmation of candidates and evidence urine is the most sensitive body fluid for non-invasive detection. Prostate 69:1257–1269Google Scholar
  11. 11.
    Wu T, Du Y, Han J, Singh S, Xie C et al (2013) Urinary angiostatin-a novel putative marker of renal pathology chronicity in lupus nephritis. Molecular & Cellular Proteomics 12:1170–1179Google Scholar
  12. 12.
    Huang JT, Chaudhuri R, Albarbarawi O, Barton A, Grierson C et al (2012) Clinical validity of plasma and urinary desmosine as biomarkers for chronic obstructive pulmonary disease. Thorax 67:502–508Google Scholar
  13. 13.
    Smith ER, Zurakowski D, Saad A, Scott RM, Moses MA (2008) Urinary biomarkers predict brain tumor presence and response to therapy. Clin Cancer Res 14:2378–2386Google Scholar
  14. 14.
    Shao C, Li M, Li X, Wei L, Zhu L et al (2011) A tool for biomarker discovery in the urinary proteome: a manually curated human and animal urine protein biomarker database. Mol Cell Proteomics 10:M111 010975Google Scholar
  15. 15.
    Jia L, Zhang L, Shao C, Song E, Sun W et al (2009) An attempt to understand kidney’s protein handling function by comparing plasma and urine proteomes. PLoS One 4:e5146Google Scholar
  16. 16.
    Gao Y (2014) Roadmap to the Urine Biomarker Era. MOJ Proteomics Bioinformatics 1:00005Google Scholar
  17. 17.
    Zhao M, Li M, Li X, Shao C, Yin J et al (2014) Dynamic changes of urinary proteins in a focal segmental glomerulosclerosis rat model. Proteome science 12:42Google Scholar
  18. 18.
    Jia L, Liu X, Liu L, Li M, Gao Y (2014) Urimem, a membrane that can store urinary proteins simply and economically, makes the large-scale storage of clinical samples possible. Sci China Life Sci 57:336–339Google Scholar
  19. 19.
    Masola V, Gambaro G, Tibaldi E, Brunati AM, Gastaldello A et al (2012) Heparanase and syndecan-1 interplay orchestrates fibroblast growth factor-2-induced epithelial-mesenchymal transition in renal tubular cells. J Biol Chem 287:1478–1488Google Scholar
  20. 20.
    Chen Y, Gu B, Wu S, Sun W, Ma S et al (2009) Using enrichment index for quality control of secretory protein sample and identification of secretory proteins. J Mass Spectrom 44:397–403Google Scholar
  21. 21.
    Nagaraj N, Mann M (2011) Quantitative analysis of the intra- and inter-individual variability of the normal urinary proteome. J Proteome Res 10:637–645Google Scholar
  22. 22.
    Molina L, Salvetat N, Ameur RB, Peres S, Sommerer N et al (2011) Analysis of the variability of human normal urine by 2D-GE reveals a “public” and a “private” proteome. J Proteomics 75:70–80Google Scholar
  23. 23.
    Gao Y (2014) Opportunities You Do Not Want to Miss and Risks You Cannot Afford to Take in Urine Biomarker Era. MOJ Proteomics Bioinformatics 1:00003Google Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2015

Authors and Affiliations

  1. 1.National Key Laboratory of Medical Molecular Biology, Department of Pathophysiology, Institute of Basic Medical SciencesChinese Academy of Medical Sciences/School of Basic MedicineBeijingChina

Personalised recommendations